Bausch Health Companies Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Tom Appio
Chief executive officer
US$15.9m
Total compensation
CEO salary percentage | 7.4% |
CEO tenure | 2yrs |
CEO ownership | 0.1% |
Management average tenure | 2.2yrs |
Board average tenure | 7.9yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Mar 31 2024 | n/a | n/a | -US$455m |
Dec 31 2023 | US$16m | US$1m | -US$592m |
Sep 30 2023 | n/a | n/a | -US$963m |
Jun 30 2023 | n/a | n/a | -US$186m |
Mar 31 2023 | n/a | n/a | -US$357m |
Dec 31 2022 | US$13m | US$1m | -US$225m |
Sep 30 2022 | n/a | n/a | US$254m |
Jun 30 2022 | n/a | n/a | US$43m |
Mar 31 2022 | n/a | n/a | -US$407m |
Dec 31 2021 | US$10m | US$854k | -US$948m |
Sep 30 2021 | n/a | n/a | -US$1b |
Jun 30 2021 | n/a | n/a | -US$1b |
Mar 31 2021 | n/a | n/a | -US$1b |
Dec 31 2020 | US$4m | US$775k | -US$560m |
Sep 30 2020 | n/a | n/a | -US$2b |
Jun 30 2020 | n/a | n/a | -US$2b |
Mar 31 2020 | n/a | n/a | -US$2b |
Dec 31 2019 | US$4m | US$769k | -US$2b |
Sep 30 2019 | n/a | n/a | -US$616m |
Jun 30 2019 | n/a | n/a | -US$917m |
Mar 31 2019 | n/a | n/a | -US$2b |
Dec 31 2018 | US$4m | US$730k | -US$4b |
Sep 30 2018 | n/a | n/a | -US$3b |
Jun 30 2018 | n/a | n/a | -US$2b |
Mar 31 2018 | n/a | n/a | -US$805m |
Dec 31 2017 | US$3m | US$650k | US$2b |
Compensation vs Market: Tom's total compensation ($USD15.88M) is above average for companies of similar size in the MX market ($USD1.52M).
Compensation vs Earnings: Tom's compensation has increased whilst the company is unprofitable.
CEO
Tom Appio (61 yo)
2yrs
Tenure
US$15,878,578
Compensation
Mr. Thomas J. Appio, also known as Tom, serves as the Chief Executive Officer & Director at Bausch Health Companies Inc. and served as Chief Executive Officer of Pharma Business and served as President & C...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | 2yrs | US$15.88m | 0.11% $ 50.3m | |
Senior VP | 1.9yrs | US$1.40m | 0.0045% $ 2.0m | |
Executive VP & General Counsel | 2yrs | US$3.16m | 0.023% $ 9.9m | |
Senior VP & COO | 2.3yrs | no data | 0.024% $ 10.7m | |
Senior Vice President of Sales & Salix | 1.3yrs | no data | no data | |
Senior VP & Chief HR Officer | 2.3yrs | no data | no data | |
Chief Medical Officer and President of R&D | no data | no data | no data | |
Executive VP of Market Access | 3.9yrs | no data | no data | |
Senior VP & Chief Quality Officer | 2.3yrs | no data | no data | |
Senior Vice President of Europe & Canada | 2.3yrs | no data | no data | |
Senior Vice President of Ortho Dermatologics | no data | no data | no data | |
Senior Vice President of Solta Medical | 1.3yrs | no data | no data |
2.2yrs
Average Tenure
50yo
Average Age
Experienced Management: BHC N's management team is considered experienced (2.2 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | 2yrs | US$15.88m | 0.11% $ 50.3m | |
Lead Independent Director | 8.2yrs | US$763.35k | 0.0031% $ 1.4m | |
Independent Chairman | 1.9yrs | US$812.50k | 0.000060% $ 26.4k | |
Independent Director | 15.8yrs | US$389.55k | 0.0018% $ 790.9k | |
Chairman of External Advisory Board | no data | US$2.00m | no data | |
Member of the External Advisory Board | 15.2yrs | no data | no data | |
Member of the External Advisory Board | 15.2yrs | no data | no data | |
Member of the External Advisory Board | 15.2yrs | no data | no data | |
Independent Director | 3.2yrs | US$691.72k | 0.00020% $ 87.9k | |
Independent Director | 7.9yrs | US$704.55k | 0% $ 0 | |
Independent Director | 7.9yrs | US$377.50k | 0.011% $ 5.0m | |
Independent Director | 3.2yrs | US$381.31k | 0.031% $ 13.5m |
7.9yrs
Average Tenure
68yo
Average Age
Experienced Board: BHC N's board of directors are considered experienced (7.9 years average tenure).